NCT07666594Not yet recruiting
Mobile App-Based Yoga and Meditation in Rheumatoid Arthritis
Effectiveness of a Mobile Application-Based Yoga and Meditation Program in Patients With Rheumatoid Arthritis: A Single-Blind Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 24 Jun 2026
Brief summary (registry, in English)
The goal of this single-blind, randomized controlled trial is to evaluate the clinical effectiveness and short-term economic impact of a mobile application-based, personalized yoga and meditation program in adult patients with Rheumatoid Arthritis (RA). The main questions it aims to answer are: Does an 8-week digital yoga and meditation intervention reduce anxiety and improve other clinical/psychological outcomes (such as depression, pulmonary function, reaction time, quality of life, and stress) compared to standard medical care? Does this digital intervention reduce short-term healthcare utilization and associated direct medical costs? Researchers will compare the Mobile App Group (receiving personalized yoga and meditation via the Meditopia app) to a Control Group (receiving usual medical care) to evaluate the effectiveness and cost-efficiency of the intervention. Participants in the experimental group will: Use a mobile application to practice 15-30 minutes of yoga and 15-30 minutes of meditation daily, at least 4 days a week over an 8-week period. Complete clinical, psychometric, and economic assessments at baseline, week 4, and week 8.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- First submitted
- 15 May 2026
- Start date
- Jun 2026
- Primary completion date
- May 2027
- Lead sponsor
- Tugba Civi Karaaslan
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07666594
What you commit to
- Study type: Interventional
- Planned participants: 102
- From Jun 2026 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe psychiatric diagnoses (e.g., psychosis, bipolar disorder, or severe major depression).
- Severe cognitive impairment or dementia.
Other
- Presence of acute RA flare-ups.
- Pregnancy.
- Regular practice of meditation or mindfulness within the last 6 months.
- Participation in any other stress management program within the last 3 months.
- Receipt of mental health services within the last 6 months.
Who the study is looking for
- Adults aged between 18 and 65 years.
- Diagnosed with Rheumatoid Arthritis (RA) by a rheumatologist.
- Disease in a stable phase (remission or low disease activity).
- Access to a smartphone or tablet and sufficient proficiency in using mobile applications.
- Cognitive sufficiency to provide written and verbal informed consent in Turkish.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.